Join
Live feed
·
INSIDERFilingvia Quantisnow
SELLAS Life Sciences Group Inc. logo

Director Kalin Katherine Bach was granted 12,500 shares, increasing direct ownership by 147% to 21,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SLS· SELLAS Life Sciences Group Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SLS (SELLAS Life Sciences Group Inc.) and more on Quantisnow.